Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Veerhealth Care secured its biggest single order worth ₹6.16 crores from a leading Indian FMCG company for skincare products. This order, representing 85% of Q3 FY26 revenues, will be executed within 45 days.
Apr 20 2026 16:04:00
Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Veerhealth Care Ltd secured a ₹6.16 crore domestic order for skincare products. The order from an Indian FMCG company is to be executed within 45 days, contributing to turnover growth.
Apr 17 2026 17:04:00
Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Veerhealth Care Ltd. submitted newspaper publication for a postal ballot notice. This ballot seeks shareholder approval for the issuance of securities to both promoter and non-promoter groups, fulfilling regulatory obligations.
Apr 16 2026 16:04:00
Veerhealth Care Ltd - 511523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Veerhealth Care issued a corrigendum to its Postal Ballot Notice. It clarifies the preferential issue of up to 1,00,00,000 fully convertible warrants, valued at ₹20.25 crore, intended for manufacturing capacity expansion and general corporate purposes.
Apr 15 2026 17:04:00
Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Veerhealth Care Ltd. secured an international order worth $160,650 (approx. ₹1.5 crores) for body care products. The order from a New York-based company is to be executed within 45 days.
Apr 11 2026 12:04:00
Veerhealth Care Ltd - 511523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Veerhealth Care seeks shareholder nod for preferential allotment of 1 crore fully convertible warrants at ₹20.25 each, raising ₹20.25 crores. Funds to be utilized for expanding manufacturing capacity by October 2027.
Mar 31 2026 17:03:00
Veerhealth Care Ltd - 511523 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Veerhealth Care Limited ('Company') In Accordance With Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Veerhealth Care's board approved a preferential issue of fully convertible warrants aggregating up to ₹21 crores. These warrants will be issued to promoter and non-promoter categories and are convertible into equity shares within 18 months, subject to shareholder approval.
Mar 28 2026 16:03:00
Read More